Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1979 1
1980 1
1982 1
1983 1
1984 2
1985 1
1989 1
1994 1
1995 2
1996 1
2001 2
2002 1
2004 2
2005 2
2006 5
2008 1
2009 2
2011 3
2012 2
2013 5
2014 2
2015 3
2016 4
2017 2
2018 3
2019 5
2020 3
2021 4
2022 5
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Axitinib: A Photoswitchable Approved Tyrosine Kinase Inhibitor.
Schmidt D, Rodat T, Heintze L, Weber J, Horbert R, Girreser U, Raeker T, Bußmann L, Kriegs M, Hartke B, Peifer C. Schmidt D, et al. Among authors: bussmann l. ChemMedChem. 2018 Nov 20;13(22):2415-2426. doi: 10.1002/cmdc.201800531. Epub 2018 Nov 5. ChemMedChem. 2018. PMID: 30199151
Analyzing expression and phosphorylation of the EGF receptor in HNSCC.
Kriegs M, Clauditz TS, Hoffer K, Bartels J, Buhs S, Gerull H, Zech HB, Bußmann L, Struve N, Rieckmann T, Petersen C, Betz CS, Rothkamm K, Nollau P, Münscher A. Kriegs M, et al. Among authors: bussmann l. Sci Rep. 2019 Sep 19;9(1):13564. doi: 10.1038/s41598-019-49885-5. Sci Rep. 2019. PMID: 31537844 Free PMC article.
Increased replication stress and R-loop accumulation in EGFRvIII-expressing glioblastoma present new therapeutic opportunities.
Struve N, Hoffer K, Weik AS, Riepen B, Krug L, Cetin MH, Burmester J, Ott L, Liebing J, Gatzemeier F, Müller-Goebel J, Gerbach M, Bußmann L, Parplys AC, Unger K, Mansour WY, Schüller U, Rieckmann T, Petersen C, Rothkamm K, Short SC, Kriegs M. Struve N, et al. Among authors: bussmann l. Neurooncol Adv. 2021 Dec 4;4(1):vdab180. doi: 10.1093/noajnl/vdab180. eCollection 2022 Jan-Dec. Neurooncol Adv. 2021. PMID: 35274102 Free PMC article.
Kinomic comparison of snap frozen and ex vivo-cultured head and neck tumors.
Berger J, Zech HB, Hoffer K, von Bargen CM, Nordquist L, Bussmann L, Gatzemeier F, Busch CJ, Möckelmann N, Münscher A, Betz CS, Petersen C, Rothkamm K, Rieckmann T, Köcher S, Kriegs M. Berger J, et al. Among authors: bussmann l. Oral Oncol. 2021 Dec;123:105603. doi: 10.1016/j.oraloncology.2021.105603. Epub 2021 Nov 16. Oral Oncol. 2021. PMID: 34798574 Free article.
Early relapse detection by monitoring of circulating cell-free DNA in patients with localized head and neck squamous cell carcinoma: A subgroup analysis of the multicenter randomized clinical trial IMSTAR-HN.
Jonas H, Simnica D, Bußmann L, Zech H, Doescher J, Laban S, Busch CJ, Binder M. Jonas H, et al. Among authors: bussmann l. Oral Oncol. 2022 Mar;126:105733. doi: 10.1016/j.oraloncology.2022.105733. Epub 2022 Jan 29. Oral Oncol. 2022. PMID: 35093699 Clinical Trial. No abstract available.
64 results